Patient-Specific Modeling of Diffuse Large B-Cell Lymphoma
Personalized medicine aims to tailor treatment to patients based on their individual genetic or molecular background. Especially in diseases with a large molecular heterogeneity, such as diffuse large B-cell lymphoma (DLBCL), personalized medicine has the potential to improve outcome and/or to reduc...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/fa11e8ee04db491da78735748c189709 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|